Esther Berry

464 total citations
14 papers, 366 citations indexed

About

Esther Berry is a scholar working on Pediatrics, Perinatology and Child Health, Obstetrics and Gynecology and Infectious Diseases. According to data from OpenAlex, Esther Berry has authored 14 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 5 papers in Obstetrics and Gynecology and 3 papers in Infectious Diseases. Recurrent topics in Esther Berry's work include Prenatal Screening and Diagnostics (8 papers), Pregnancy and preeclampsia studies (4 papers) and Parvovirus B19 Infection Studies (3 papers). Esther Berry is often cited by papers focused on Prenatal Screening and Diagnostics (8 papers), Pregnancy and preeclampsia studies (4 papers) and Parvovirus B19 Infection Studies (3 papers). Esther Berry collaborates with scholars based in United Kingdom, Canada and Hungary. Esther Berry's co-authors include Jennifer A. Crossley, J. M. Connor, David A. Aitken, James N. Macri, Kevin Spencer, D.A. Aitken, K. H. Nicolaides, John Burn, Robert Love and J Doran and has published in prestigious journals such as Clinica Chimica Acta, BJOG An International Journal of Obstetrics & Gynaecology and Experimental Biology and Medicine.

In The Last Decade

Esther Berry

14 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther Berry United Kingdom 10 309 181 78 66 63 14 366
L. Tului Italy 8 386 1.2× 181 1.0× 146 1.9× 71 1.1× 60 1.0× 12 442
Wayne J. Huttly United Kingdom 14 491 1.6× 232 1.3× 112 1.4× 130 2.0× 94 1.5× 30 578
Douglas W. Hershey United States 6 339 1.1× 57 0.3× 59 0.8× 240 3.6× 58 0.9× 8 426
Niels Hahnemann Denmark 13 312 1.0× 43 0.2× 134 1.7× 65 1.0× 24 0.4× 17 427
Vanina Castaigne France 11 140 0.5× 69 0.4× 31 0.4× 67 1.0× 24 0.4× 25 280
Sigal Heifetz Israel 5 221 0.7× 33 0.2× 75 1.0× 180 2.7× 73 1.2× 6 335
Yumi Sugito Japan 8 346 1.1× 102 0.6× 18 0.2× 164 2.5× 52 0.8× 8 392
M. Pruggmayer Germany 10 248 0.8× 91 0.5× 88 1.1× 21 0.3× 24 0.4× 17 316
Melanie Pastuck Canada 9 282 0.9× 89 0.5× 37 0.5× 38 0.6× 71 1.1× 15 348
Sung Shin Shim South Korea 9 114 0.4× 47 0.3× 52 0.7× 105 1.6× 41 0.7× 22 283

Countries citing papers authored by Esther Berry

Since Specialization
Citations

This map shows the geographic impact of Esther Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Berry more than expected).

Fields of papers citing papers by Esther Berry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Berry. The network helps show where Esther Berry may publish in the future.

Co-authorship network of co-authors of Esther Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Berry. A scholar is included among the top collaborators of Esther Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Berry. Esther Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Berry, Esther, et al.. (2000). Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?. Prenatal Diagnosis. 20(4). 311–317. 29 indexed citations
2.
Aitken, David A., Esther Berry, Jennifer A. Crossley, et al.. (1999). Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies. Prenatal Diagnosis. 19(8). 706–710. 40 indexed citations
3.
Aitken, David A., Esther Berry, Jennifer A. Crossley, et al.. (1999). Second‐trimester pregnancy associated plasma protein‐A levels are reduced in Cornelia de Lange syndrome pregnancies. Prenatal Diagnosis. 19(8). 706–710. 3 indexed citations
4.
Berry, Esther, David A. Aitken, Jennifer A. Crossley, James N. Macri, & J. M. Connor. (1997). Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters. BJOG An International Journal of Obstetrics & Gynaecology. 104(7). 811–817. 51 indexed citations
5.
Aitken, David A., et al.. (1996). HEAT-STABLE AND IMMUNOREACTIVE PLACENTAL ALKALINE PHOSPHATASE IN MATERNAL SERUM FROM DOWN'S SYNDROME AND TRISOMY 18 PREGNANCIES. Prenatal Diagnosis. 16(11). 1051–1054. 12 indexed citations
6.
Crossley, Jennifer A., Esther Berry, David A. Aitken, & J. M. Connor. (1996). INSULIN‐DEPENDENT DIABETES MELLITUS AND PRENATAL SCREENING RESULTS: CURRENT EXPERIENCE FROM A REGIONAL SCREENING PROGRAMME. Prenatal Diagnosis. 16(11). 1039–1042. 16 indexed citations
7.
Berry, Esther, David A. Aitken, Jennifer A. Crossley, James N. Macri, & J. M. Connor. (1995). Analysis of maternal serum alpha‐fetoprotein and free beta human chorionic gonadotrophin in the first trimester: Implications for down's syndrome screening. Prenatal Diagnosis. 15(6). 555–565. 26 indexed citations
8.
Spencer, Kevin, D.A. Aitken, Jennifer A. Crossley, et al.. (1994). First Trimester Biochemical Screening for Trisomy 21: The Role of Free Beta hCG, Alpha Fetoprotein and Pregnancy Associated Plasma Protein A. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 31(5). 447–454. 58 indexed citations
9.
Crossley, Jennifer A., David A. Aitken, Esther Berry, & J. M. Connor. (1994). Impact of a Regional Screening Programme Using Maternal Serum a Fetoprotein (AFP) and Human Chorionic Gonadotrophin (hCG) on the Birth Incidence of Down's Syndrome in the West of Scotland. Journal of Medical Screening. 1(3). 180–183. 33 indexed citations
10.
Spencer, Kevin, James N. Macri, Ronald Anderson, et al.. (1993). Dual Analyte Immunoassay in Neural Tube Defect and Down's Syndrome Screening: Results of a Multicentre Clinical Trial. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 30(4). 394–401. 25 indexed citations
11.
Aitken, David A., Jennifer A. Crossley, Esther Berry, et al.. (1993). First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defects. Prenatal Diagnosis. 13(8). 681–689. 59 indexed citations
12.
Jamieson, E C, et al.. (1988). Combined enzymatic assay of phosphatidylglycerol and phosphatidylcholine in amniotic fluid. Clinica Chimica Acta. 171(2-3). 175–185. 1 indexed citations
13.
Jamieson, E C, et al.. (1986). Assessment of the AmnioStat-FLM immunoagglutination test for phosphatidylglycerol in amniotic fluid. Clinica Chimica Acta. 156(3). 271–277. 5 indexed citations
14.
Love, Robert, et al.. (1955). A Simple Stain for Mitochondria.. Experimental Biology and Medicine. 88(4). 666–669. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026